Two pharm picks# Stock
r*5
1 楼
ACAD and CHTP: Both have drugs to submit to FDA for approval. Especially
ACAD, it has very positive phase III results. Before FDA final decision,
there is no reason for those to drop. But do your research or not complaint
even if you lose $. If you want a steady one, PFE is decent candidate, with
good dividend, solid growth, and plenty of $. I have all of them.
ACAD, it has very positive phase III results. Before FDA final decision,
there is no reason for those to drop. But do your research or not complaint
even if you lose $. If you want a steady one, PFE is decent candidate, with
good dividend, solid growth, and plenty of $. I have all of them.
